SGHT logo

Sight Sciences (SGHT) Company Overview

Profile

Full Name:

Sight Sciences, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

July 15, 2021

Indexes:

Not included

Website:

http://www.sightsciences.com

Description:

Sight Sciences (SGHT) is a medical technology company focused on developing innovative solutions for eye care. They create devices and treatments to improve vision and reduce eye-related diseases, helping patients and healthcare providers enhance the quality of eye care. Their goal is to advance ophthalmic health.

Key Details

Price

$2.79

Market Cap

$142.12 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$79.87 M(-1.47% YoY)

Annual EPS

-$1.03(+9.65% YoY)

PE Ratio

-

Annual ROE

-49.59%

Annual Debt To Equity

0.45

Beta

1.76

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Mar 5, 2025

Recent annual earnings:

Mar 5, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Mar 6, 25 Stifel
Buy
Mar 6, 25 Piper Sandler
Neutral
Mar 6, 25 Needham
Hold
Mar 6, 25 Lake Street
Hold
Mar 4, 25 Citigroup
Neutral
Feb 6, 25 Stifel
Buy
Jan 27, 25 UBS
Buy
Jan 15, 25 Lake Street
Hold
Jan 14, 25 Needham
Hold
Dec 11, 24 Citigroup
Neutral

Screeners with SGHT included

Growing Shares Outstanding
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
NASDAQ Listed Companies
Biggest stock gainers today

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$2.79
SGHT price is $2.79

Price All-time High

$39.10
SGHT price is currently -92.86% below its historical high of $39.10

Price Analysts Target

$3.25
SGHT price is currently -14.15% lower than the consensus analysts' forecast

Price Today Change

+19.74%
SGHT price is up +19.74% today

Price YTD Change

-23.35%
SGHT price is down -23.35% since January 1st

Price 3-Year Change

-79.84%
SGHT price is down -79.84% over the past 3 years

Market cap

Market Cap

$142.12 M
SGHT market capitalization is $142.12 million

Market Cap 3-Year Change

-78.38%
SGHT market capitalization is down -78.38% over the past 3 years

Market Cap All-time High

$1.83 B
SGHT market capitalization is currently -92.23% below its historical high of $1.83 billion

Market Cap Sector Rank

50.95%
SGHT market capitalization is higher than 50.95% of companies in Healthcare sector

Technical

Beta

1.76
SGHT beta is 1.76

200-day SMA

$5.11
SGHT price is currently -45.44% below its 200-day simple moving average

14-day RSI

41.10
SGHT 14-day relative strength index is 41.10

30-day Relative Volume

1.67
SGHT 30-day relative volume is 1.67

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$79.87 M
SGHT annual revenue is $79.87 million

Annual Revenue Analysts Estimate

$71.92 M
SGHT annual revenue is currently +11.05% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-1.47%
SGHT annual revenue is down -1.47% year-on-year

Annual Revenue Sector Rank

52.99%
SGHT annual revenue is higher than 52.99% of companies in Healthcare sector

Profit

Annual Gross Profit

$68.28 M
SGHT annual gross profit is $68.28 million

Annual Gross Margin

85.50%
SGHT annual gross profit margin is 85.50%

Annual Operating Profit

-$50.53 M
SGHT annual operating income is -$50.53 million

Annual Operating Margin

-63.27%
SGHT annual operating profit margin is -63.27%

Annual Net Income

-$51.51 M
SGHT annual net profit is -$51.51 million

Annual Net Margin

-64.49%
SGHT annual net profit margin is -64.49%

EPS

Annual EPS

-$1.03
SGHT annual earnings per share is -$1.03

Annual EPS Analysts Estimate

-$0.95
SGHT annual earnings per share is currently +7.85% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+9.65%
SGHT annual earnings per share is up +9.65% year-on-year

Annual EPS Sector Rank

58.72%
SGHT annual earnings per share is higher than 58.72% of companies in Healthcare sector

ROA & ROE

Annual ROA

-33.29%
SGHT annual return on assets is -33.29%

Annual ROE

-49.59%
SGHT annual return on equity is -49.59%

EBIT & EBITDA

Annual EBIT

-$46.61 M
SGHT annual earnings before interest & taxes is -$46.61 million

Annual EBITDA

-$46.61 M
SGHT annual EBITDA is -$46.61 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
SGHT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
SGHT price to earnings ratio is unknown

PB Ratio

PB Ratio

1.62
SGHT price to book ratio is 1.62

PB Ratio Sector Rank

54.53%
SGHT price to book ratio is higher than 54.53% of companies in Healthcare sector

PS Ratio

PS Ratio

1.78
SGHT price to sales ratio is 1.78

PS Ratio Sector Rank

38.07%
SGHT price to sales ratio is higher than 38.07% of companies in Healthcare sector

Enterprise value

Enterprise Value

$61.65 M
SGHT enterprise value is $61.65 million

Enterprise Value Sector Rank

42.74%
SGHT enterprise value is higher than 42.74% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.34
SGHT EV/EBITDA is -1.34

EV/EBITDA Sector Rank

40.81%
SGHT EV/EBITDA is higher than 40.81% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

9.04
SGHT annual current ratio is 9.04

Annual Quick Ratio

8.63
SGHT annual quick ratio is 8.63

Leverage

Annual Debt To Equity

0.45
SGHT annual debt to equity ratio is 0.45

Annual Interest Coverage Ratio

-10.00
SGHT annual interest coverage ratio is -10.00

Risk & Stability

Piotroski F-Score

3
SGHT piotroski f-score is 3

Altman Z-Score

-1.33
SGHT altman z-score is -1.33

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$142.84 M
SGHT annual total assets is $142.84 million

Annual Non Current Assets

$3.06 M
SGHT annual long term assets is $3.06 million

Annual Current Assets

$139.77 M
SGHT annual total current assets is $139.77 million

Annual Cash & Cash Equivalents

$120.36 M
SGHT annual cash & cash equivalents is $120.36 million

Equity

Annual Book Value

$87.52 M
SGHT annual book value is $87.52 million

Annual Working Capital

$124.31 M
SGHT annual working capital is $124.31 million

Liabilities

Annual Total Liabilities

$55.32 M
SGHT annual total liabilities is $55.32 million

Annual Total Long Term Liabilities

$39.85 M
SGHT annual total long term liabilities is $39.85 million

Annual Current Liabilities

$15.47 M
SGHT annual total current liabilities is $15.47 million

Annual Accounts Payable

$1.69 M
SGHT annual accounts payable is $1.69 million

Debt

Annual Total Debt

$39.89 M
SGHT annual total debt is $39.89 million

Annual Total Debt 1-Year Change

+12.64%
SGHT annual total debt is up +12.64% year-on-year

Annual Long Term Debt

$39.36 M
SGHT annual long term debt is $39.36 million

Annual Short Term Debt

$533.00 K
SGHT annual short term debt is $533.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$130.40 M
SGHT annual total expenses is $130.40 million

Annual Operating Expenses

$118.82 M
SGHT annual total operating expenses is $118.82 million

Annual Cost Of Goods Sold

$11.58 M
SGHT annual cost of goods sold is $11.58 million

Annual SGA

$100.83 M
SGHT annual SGA is $100.83 million

Annual D&A

$712.00 K
SGHT annual depreciation & amortization is $712.00 thousand

Annual Interest Expense

$4.66 M
SGHT annual interest expense is $4.66 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$22.35 M
SGHT annual cash flow from operations is -$22.35 million

Annual CFO 1-Year Change

+52.63%
SGHT annual cash flow from operations is up +52.63% year-on-year

Annual CFI

-$385.00 K
SGHT annual cash flow from investing activities is -$385.00 thousand

Annual CFI 1-Year Change

+51.33%
SGHT annual cash flow from investing activities is up +51.33% year-on-year

Annual CFF

$4.96 M
SGHT annual cash flow from financing activities is $4.96 million

Annual CFF 1-Year Change

+349.64%
SGHT annual cash flow from financing activities is up +349.64% year-on-year

Free CashFlow

Annual FCF

-$22.74 M
SGHT annual free cash flow is -$22.74 million

Annual FCF 1-Year Change

+52.61%
SGHT annual free cash flow is up +52.61% year-on-year

CAPEX

Annual CAPEX

$385.00 K
SGHT annual capital expenditures is $385.00 thousand

Annual CAPEX 1-Year Change

-51.33%
SGHT annual capital expenditures is down -51.33% year-on-year

Institutional Ownership

Similar stocks

Sagimet Biosciences (SGMT)
ADAP logo
Adaptimmune Therapeutics (ADAP)
INFU logo
InfuSystem Holdings (INFU)
Elutia (ELUT)
CHRS logo
Coherus BioSciences (CHRS)
CSBR logo
Champions Oncology (CSBR)
LCTX logo
Lineage Cell Therapeutics (LCTX)
STRO logo
Sutro Biopharma (STRO)
ZJYL logo
Jin Medical International (ZJYL)

FAQ

  • What is the ticker symbol for Sight Sciences?
  • Does Sight Sciences pay dividends?
  • What sector is Sight Sciences in?
  • What industry is Sight Sciences in?
  • What country is Sight Sciences based in?
  • When did Sight Sciences go public?
  • Is Sight Sciences in the S&P 500?
  • Is Sight Sciences in the NASDAQ 100?
  • Is Sight Sciences in the Dow Jones?
  • When was Sight Sciences's last earnings report?
  • When does Sight Sciences report earnings?
  • Should I buy Sight Sciences stock now?

What is the ticker symbol for Sight Sciences?

The ticker symbol for Sight Sciences is NASDAQ:SGHT

Does Sight Sciences pay dividends?

No, Sight Sciences does not pay dividends

What sector is Sight Sciences in?

Sight Sciences is in the Healthcare sector

What industry is Sight Sciences in?

Sight Sciences is in the Medical Devices industry

What country is Sight Sciences based in?

Sight Sciences is headquartered in United States

When did Sight Sciences go public?

Sight Sciences's initial public offering (IPO) was on July 15, 2021

Is Sight Sciences in the S&P 500?

No, Sight Sciences is not included in the S&P 500 index

Is Sight Sciences in the NASDAQ 100?

No, Sight Sciences is not included in the NASDAQ 100 index

Is Sight Sciences in the Dow Jones?

No, Sight Sciences is not included in the Dow Jones index

When was Sight Sciences's last earnings report?

Sight Sciences's most recent earnings report was on Mar 5, 2025

When does Sight Sciences report earnings?

The next expected earnings date for Sight Sciences is May 2, 2025

Should I buy Sight Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions